Compare · HSIC vs MCK
HSIC vs MCK
Side-by-side comparison of Henry Schein Inc. (HSIC) and McKesson Corporation (MCK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both companies sit in the Health Care sector. HSIC focuses on Medical Specialities, while MCK focuses on Other Pharmaceuticals.
- MCK is the larger of the two at $125.20B, about 13.2x HSIC ($9.47B).
- MCK has been more active in the news (11 items in the past 4 weeks vs 9 for HSIC).
- Both have 25 recent analyst ratings on file.
- Company
- Henry Schein Inc.
- McKesson Corporation
- Price
- -
- -
- Market cap
- $9.47B
- $125.20B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- 1995
- News (4w)
- 9
- 11
- Recent ratings
- 25
- 25
Henry Schein Inc.
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest HSIC
- Henry Schein Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Henry Schein Updates Presentation of Non-GAAP Financial Measures
- Amendment: SEC Form SCHEDULE 13G/A filed by Henry Schein Inc.
- CareQuest and Henry Schein Launch the BRIDGE Health Network to Advance Dental-Medical Integration
- New insider Caprais Emmanuel claimed no ownership of stock in the company (SEC Form 3)
- Henry Schein to Participate in Upcoming Investor Conferences in November and December
- SEC Form 10-Q filed by Henry Schein Inc.
- Henry Schein Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
- Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET
Latest MCK
- Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open Enrollment
- Gabelli Releases Agenda for 8th Annual Healthcare Symposium
- EVP, CIO and CTO Fraga Francisco sold $716,924 worth of shares (650 units at $1,102.96) as part of a pre-agreed trading plan, decreasing direct ownership by 13% to 4,414 units (SEC Form 4)
- EVP, CIO and CTO Fraga Francisco converted options into 398 shares, covered exercise/tax liability with 157 shares and sold $630,000 worth of shares (600 units at $1,050.00) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 5,064 units (SEC Form 4)
- SEC Form 144 filed by McKesson Corporation
- SEC Form S-8 filed by McKesson Corporation
- SEC Form 10-Q filed by McKesson Corporation
- McKesson Reports Fiscal 2027 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
- McKesson Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 25-NSE filed by McKesson Corporation